BusinessCutanogen Appoints Richard Kagan, MD as Chief Medical AdvisorBy Nasdaq OMXApr 23, 2018, 12:00 PM UTC
BusinessAmarantus Subsidiary Cutanogen Corporation Announces Patent Issuance in Hong Kong Covering ESS, Pigmented ESS and Gene Therapy-Modified ESSBy Nasdaq OMXJan 4, 2018, 2:45 PM UTC
